Intracameral mydriatics in phacoemulsification cataract surgery -- a 6-year follow-up.

Abstract

PURPOSE:

To evaluate the long-term safety of intracameral mydriatics (ICM) in phacoemulsification cataract surgery compared with conventional topical mydriatics (TM).

METHODS:

A total of 45 patients were examined 6 years after phacoemulsification cataract surgery. The patients had previously participated in a prospective randomized double-blind study including 60 patients, operated with either ICM or TM. The follow-up included best-corrected visual acuity (BCVA), intraocular pressure (IOP), grade of posterior capsule opacification (PCO), YAG laser capsulotomy rate, pupil size, corneal thickness and endothelial morphology.

RESULTS:

No differences in postoperative BCVA, IOP, pupil size, PCO or YAG rate were observed between the groups. Endothelial cell loss, endothelial morphology and corneal thickness were also equivalent.

CONCLUSIONS:

Intracameral mydriatics is a safe alternative to topical mydriatics in phacoemulsification cataract surgery with no long-term disadvantages at 6-year follow-up.

• Authors: Björn Lundberg, Anders Behndig
• Journal: Acta ophthalmologica (Acta Ophthalmol) Vol. 91 Issue 3 Pg. 243-6 (May 2013) ISSN: 1755-3768 [Electronic] England
• PMID: 22405257 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
• Copyright: © 2012 The Authors. Acta Ophthalmologica © 2012 Acta Ophthalmologica Scandinavica Foundation.

Chemical References

• Mydriatics
• Ophthalmic Solutions
• Phenylephrine
• Lidocaine
• Cyclopentolate

Topics

• Administration, Topical
• Aged
• Anterior Chamber (drug effects)
• Capsule Opacification (classification, pathology, surgery)
• Cornea (drug effects)
• Corneal Endothelial Cell Loss
• Cyclopentolate (administration & dosage)
• Double-Blind Method
• Drug Therapy, Combination
• Female
• Follow-Up Studies
• Humans
• Intraocular Pressure (drug effects, physiology)
• Laser Therapy
• Lasers, Solid-State (therapeutic use)
• Lens Implantation, Intraocular
• Lidocaine (administration & dosage)
• Male
• Mydriatics (administration & dosage)
• Ophthalmic Solutions
• Phacoemulsification
• Phenylephrine (administration & dosage)
• Prospective Studies
• Pupil (drug effects)
• Visual Acuity (drug effects, physiology)